|
The randomized trials that have guided the use of invasive cardiovascular interventions — both surgical and nonsurgical — over the past 12 years are not always designed to provide answers to meaningful clinical questions, new research suggests. Moreover, industry funding appears to influence how studies are conducted and reported, in both good and bad ways.
|